Global law firm White & Case LLP has expanded its Global Mergers & Acquisitions (M&A) Practice and Global Life Sciences and Healthcare Industry Group with the addition of Nicole Daley as a partner in Boston. Daley joins White & Case from A&O Shearman, where she was a partner.
Tags: White & Case LLP | BostonBanking & Finance Partner Anne Seymour Rejoins Weil
Morgan Lewis Strengthens Life Sciences IP Capabilities in Boston with Chad Davis, Ph.D.
Morgan Lewis welcomes Chad Davis, Ph.D. as a partner in the firm’s intellectual property (IP) practice, resident in Boston. Dr. Davis joins from Dechert, bringing extensive experience in global patent portfolio strategy, patent prosecution, IP due diligence, infringement and validity analyses, post-grant proceedings, and IP-related agreements. With a doctorate in chemistry, Dr. Davis is deeply embedded in the Boston life sciences community and counsels and implements patent strategies for biotech, pharmaceutical, and chemical companies, as well as their investors, on the development, protection, and commercialization of complex scientific innovations.
Tags: Morgan, Lewis & Bockius LLP | BostonGreenberg Traurig Expands Capital Markets Team in Boston with Addition of Michael J. Minahan
Global law firm Greenberg Traurig, LLP continues its strategic expansion in Boston with the addition of Michael J. Minahan as a shareholder in the firm’s Corporate and Capital Markets Practices. He joins from Goodwin Procter LLP.
Cooley Adds Patent Counseling and Prosecution Team in Boston
Saul Ewing Expands its Boston Office With Experienced Intellectual Property Partner John Powell
Saul Ewing LLP has expanded its Intellectual Property Practice in the firm’s Boston office with the hiring of Partner John Powell, who brings more than 30 years of experience helping clients strategically build and manage their patent portfolios, along with Associate Kurt Hoppmann, who focuses primarily on patent applications and prosecution. Powell arrives from Sunstein LLP where he served as Partner and Patent Group Chair.
Tags: Saul Ewing LLP | BostonCooley Strengthens Life Sciences Capabilities with Key Additions on Both Coasts
Cooley has expanded its life sciences corporate partnering and licensing practice with the addition of partners Sarah Hogan and Jenna Ventorino in the Boston office and partner Stephen Abreu in the San Francisco office. The three new attorneys enhance Cooley’s established position as a leading strategic advisor across the life sciences industry. Hogan and Ventorino join from WilmerHale, and Abreu joins from Sidley Austin.
Tags: Cooley LLP | Boston | San FranciscoCooley Expands Debt Finance Capabilities to Meet Private Equity Demand With New Partner in Boston
Dallas Cruz has joined Cooley as a partner in the firm’s debt finance practice based in Boston. She brings extensive experience counseling clients in a range of complex finance transactions, with a particular emphasis on representing private equity sponsors and their portfolio companies. Cruz joins Cooley from Choate Hall & Stewart, where she represented private equity sponsors, private and public company borrowers, and financial institutions in acquisition financings, asset-based credit facilities, fund financings and workouts across industries.
Tags: Cooley LLP | BostonPaul Hastings Continues Expansion in Boston
Continuing to build its Boston presence, Paul Hastings LLP today announced the addition of partner Benjamin Stein. Joining from Morgan, Lewis & Bockius LLP, where he led the corporate and business transactions practice in Boston, Stein advises public and private companies on corporate transactional matters, including registered securities offerings and private equity and debt financings.
Tags: Paul Hastings, LLP | BostonPaul Hastings Further Expands Boston Office With Leading Private Equity Partner
Further strengthening its premier global private equity practice and expanding Boston team, Paul Hastings LLP announced today that James Curley has joined the firm as a partner. Joining from Goodwin Procter LLP, Curley represents private equity firms and their portfolio companies, as well as early- and late-stage growth companies, in myriad transactions, including leveraged buyouts, add-on acquisitions and dispositions.
Tags: Paul Hastings, LLP | Boston






